74 related articles for article (PubMed ID: 7521355)
1. Chlamydia trachomatis IncA is localized to the inclusion membrane and is recognized by antisera from infected humans and primates.
Bannantine JP; Stamm WE; Suchland RJ; Rockey DD
Infect Immun; 1998 Dec; 66(12):6017-21. PubMed ID: 9826388
[TBL] [Abstract][Full Text] [Related]
2. Human genital antibody-mediated inhibition of Chlamydia trachomatis infection and evidence for ompA genotype-specific neutralization.
Ardizzone CM; Albritton HL; Lillis RA; Bagnetto CEL; Shen L; Cavacini LA; Kozlowski PA; Quayle AJ
PLoS One; 2021; 16(10):e0258759. PubMed ID: 34662351
[TBL] [Abstract][Full Text] [Related]
3. A novel synthetic peptide microarray assay detects Chlamydia species-specific antibodies in animal and human sera.
Sachse K; Rahman KS; Schnee C; Müller E; Peisker M; Schumacher T; Schubert E; Ruettger A; Kaltenboeck B; Ehricht R
Sci Rep; 2018 Mar; 8(1):4701. PubMed ID: 29549361
[TBL] [Abstract][Full Text] [Related]
4. A discrepancy of Chlamydia trachomatis incidence and prevalence trends in Finland 1983-2003.
Lyytikäinen E; Kaasila M; Hiltunen-Back E; Lehtinen M; Tasanen K; Surcel HM; Koskela P; Paavonen J
BMC Infect Dis; 2008 Dec; 8():169. PubMed ID: 19094207
[TBL] [Abstract][Full Text] [Related]
5. Chlamydia trachomatis-infected patients display variable antibody profiles against the nine-member polymorphic membrane protein family.
Tan C; Hsia RC; Shou H; Haggerty CL; Ness RB; Gaydos CA; Dean D; Scurlock AM; Wilson DP; Bavoil PM
Infect Immun; 2009 Aug; 77(8):3218-26. PubMed ID: 19487469
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Platforms for Testing Antibody Responses against the
Gwyn S; Cooley G; Goodhew B; Kohlhoff S; Banniettis N; Wiegand R; Martin DL
Am J Trop Med Hyg; 2017 Dec; 97(6):1662-1668. PubMed ID: 29016320
[TBL] [Abstract][Full Text] [Related]
7. Chlamydia trachomatis Pgp3 Antibody Persists and Correlates with Self-Reported Infection and Behavioural Risks in a Blinded Cohort Study.
Horner PJ; Wills GS; Righarts A; Vieira S; Kounali D; Samuel D; Winston A; Muir D; Dickson NP; McClure MO
PLoS One; 2016; 11(3):e0151497. PubMed ID: 26974653
[TBL] [Abstract][Full Text] [Related]
8. Immunoprofiling of Chlamydia trachomatis using whole-proteome microarrays generated by on-chip in situ expression.
Hufnagel K; Lueong S; Willhauck-Fleckenstein M; Hotz-Wagenblatt A; Miao B; Bauer A; Michel A; Butt J; Pawlita M; Hoheisel JD; Waterboer T
Sci Rep; 2018 May; 8(1):7503. PubMed ID: 29760479
[TBL] [Abstract][Full Text] [Related]
9. Challenges in Chlamydial Serology: Insights from a Belgian and a Dutch Population Cohort.
De Meyst A; Alexiou Z; Lernout T; Morré SA; Vanrompay D
Microorganisms; 2024 Mar; 12(4):. PubMed ID: 38674603
[TBL] [Abstract][Full Text] [Related]
10. Antibodies from chlamydia-infected individuals facilitate phagocytosis via Fc receptors.
Hybiske K; Paktinat S; Newman K; Patton D; Khosropour C; Roxby AC; Mugo NR; Oluoch L; Ngure K; Suchland R; Hladik F; Vojtech L
Infect Immun; 2024 Apr; 92(4):e0050323. PubMed ID: 38451079
[TBL] [Abstract][Full Text] [Related]
11. Comparison of three commercially available peptide-based immunoglobulin G (IgG) and IgA assays to microimmunofluorescence assay for detection of Chlamydia trachomatis antibodies.
Morré SA; Munk C; Persson K; Krüger-Kjaer S; van Dijk R; Meijer CJ; van Den Brule AJ
J Clin Microbiol; 2002 Feb; 40(2):584-7. PubMed ID: 11825974
[TBL] [Abstract][Full Text] [Related]
12. Low prevalence of Chlamydia pneumoniae and Mycoplasma pneumoniae among patients with symptoms of respiratory tract infections in Dutch general practices.
Meijer A; Dagnelie CF; De Jong JC; De Vries A; Bestebroer TM; Van Loon AM; Bartelds AI; Ossewaarde JM
Eur J Epidemiol; 2000; 16(12):1099-106. PubMed ID: 11484797
[TBL] [Abstract][Full Text] [Related]
13. Notice of redundancy.
Boeke A; van Valkengoed IGM; Morre S; van den Brule AJC; Deville W; Meijer C; Bouter L
Sex Transm Infect; 2001 Aug; 77(4):301. PubMed ID: 11463940
[No Abstract] [Full Text] [Related]
14. No association of anti-Chlamydia trachomatis antibodies and severity of cervical neoplasia.
Reesink-Peters N; Ossewaarde JM; Van Der Zee AG; Quint WG; Burger MP; Adriaanse AH
Sex Transm Infect; 2001 Apr; 77(2):101-2. PubMed ID: 11287686
[TBL] [Abstract][Full Text] [Related]
15. Comparison of two panels of monoclonal antibodies for determination of Chlamydia trachomatis serovars.
Ossewaarde JM; Rieffe M; de Vries A; Derksen-Nawrocki RP; Hooft HJ; van Doornum GJ; van Loon AM
J Clin Microbiol; 1994 Dec; 32(12):2968-74. PubMed ID: 7883884
[TBL] [Abstract][Full Text] [Related]
16. Enzyme immunoassay with enhanced specificity for detection of antibodies to Chlamydia trachomatis.
Ossewaarde JM; de Vries A; van den Hoek JA; van Loon AM
J Clin Microbiol; 1994 Jun; 32(6):1419-26. PubMed ID: 7521355
[TBL] [Abstract][Full Text] [Related]
17. Measurement of IgG antibodies to Chlamydia trachomatis by commercial enzyme immunoassays and immunofluorescence in sera from pregnant women and patients with infertility, pelvic inflammatory disease, ectopic pregnancy, and laboratory diagnosed Chlamydia psittaci/Chlamydia pneumoniae infection.
Jones CS; Maple PA; Andrews NJ; Paul ID; Caul EO
J Clin Pathol; 2003 Mar; 56(3):225-9. PubMed ID: 12610104
[TBL] [Abstract][Full Text] [Related]
18. An enzyme immunoassay to detect specific antibodies to protein and lipopolysaccharide antigens of Chlamydia trachomatis.
Ossewaarde JM; Manten JW; Hooft HJ; Hekker AC
J Immunol Methods; 1989 Oct; 123(2):293-8. PubMed ID: 2681425
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
